- Harold and Esther Edgerton Associate Professor of Immunology and Microbiology, Department of Food Science & Technology
- Director, Nebraska Gnotobiotic Mouse Program
Dr. Ramer-Tait has built an internationally recognized research program that focuses on how the microbes living in the human digestive tract (known as the gut microbiota) influence human health and disease. Her work also aims to develop novel dietary interventions that alter the gut microbiota to treat chronic diseases, including obesity, metabolic syndrome, and inflammatory bowel diseases. Dr. Ramer-Tait has authored over 60 peer-reviewed publications and received research funding from the Crohn’s and Colitis Foundation, the National Institutes of Health, and the US Department of Agriculture. She also co-directs the Complex Biosystems PhD program at UNL and teaches courses on immunology, microbiology, and functional foods.
Clavel T, Gomes-Neto JC, Lagkouvardos I, Ramer-Tait AE. Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes. Immunol Rev. 2017 Sep;279(1):8-22. doi: 10.1111/imr.12578. PubMed PMID: 28856739.
Perez-Munoz ME, Arrieta MC, Ramer-Tait AE, Walter J. A critical assessment of the "sterile womb" and "in utero colonization" hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017 Apr 28;5(1):48. doi: 10.1186/s40168-017-0268-4. PubMed PMID: 28454555; PubMed Central PMCID: PMC5410102.
Gomes-Neto JC, Mantz S, Held K, Sinha R, Segura Munoz RR, Schmaltz R, Benson AK, Walter J, Ramer-Tait AE. A real-time PCR assay for accurate quantification of the individual members of the Altered Schaedler Flora microbiota in gnotobiotic mice. J Microbiol Methods. 2017 Apr;135:52-62. doi: 10.1016/j.mimet.2017.02.003. PubMed PMID: 28189782; PubMed Central PMCID: PMC5365401.
Bindels LB, Segura Munoz RR, Gomes-Neto JC, Mutemberezi V, Martinez I, Salazar N, Cody EA, Quintero-Villegas MI, Kittana H, de Los Reyes-Gavilan CG, Schmaltz RJ, Muccioli GG, Walter J, Ramer-Tait AE. Resistant starch can improve insulin sensitivity independently of the gut microbiota. Microbiome. 2017 Feb 7;5(1):12. doi: 10.1186/s40168-017-0230-5. PubMed PMID: 28166818; PubMed Central PMCID: PMC5294823.
Yang J, Bindels LB, Segura Munoz RR, Martinez I, Walter J, Ramer-Tait AE, Rose DJ. Disparate metabolic responses in mice fed a high-fat diet supplemented with maize-derived non-digestible feruloylated oligo- and polysaccharides are linked to changes in the gut microbiota. PLoS One. 2016 Jan 5;11(1):e0146144. doi: 10.1371/journal.pone.0146144. PubMed PMID: 26731528; PubMed Central PMCID: PMC4701460.
Bindels LB, Walter J, Ramer-Tait AE. Resistant starches for the management of metabolic diseases. Curr Opin Clin Nutr Metab Care. 2015 Nov;18(6):559-65. doi: 10.1097/MCO.0000000000000223. PubMed PMID: 26406392; PubMed Central PMCID: PMC4612508.